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Background: Previous studies suggest that chemical constituents present in Pinus eldarica Medw (P. eldarica) nut
possess antioxidant properties that may positively influence lipid profile.
The present study was conducted to evaluate the efficacy of P. eldarica nut on the experimental atherosclerosis
development in hypercholesterolemic rabbits.
Methods: Forty male 6 months old white New Zealand rabbits (1.8–2 kg) were randomly assigned into five equal
groups. One group was kept as control (normal) group, fed on standard rabbit diet and other 4 groups were fed
on high cholesterol diet (HCD). Out of four HCD groups one group was kept as control (HCD) and other three
groups were treated with different doses (50, 100 and 200 mg/kg/day) of P. eldarica nut for 8 weeks. Percentage of
aortic wall area changes as indication of atherosclerosis development and fasting blood cholesterol, LDL, HDL and
triglyceride levels were determined in all groups.
Results: The results indicate that fasting blood cholesterol and aortic atherosclerotic involvements in 200 mg/kg/
day and 100 mg/kg/day P. eldarica nut extract treated groups significantly decreased as compared to the high
cholesterol-diet control group.
Conclusion: P. eldarica nut lowers blood cholesterol level and aortic atherosclerotic involvement in hypercholesterolemic
rabbits.
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Atherosclerotic vascular disease is a major cause of mor-
bidity and mortality worldwide [1]. Dyslipidemia is a
crucial risk factor for atherosclerosis and oxidative stress
following free radical-mediated oxidation of low-density
lipoproteins is associated with progression of atherogen-
esis and its vascular complications [2–4]. In the search
for plant foods that provide cardiovascular benefits, nuts
have recently enticed attention. Among nuts, the Iranian
pine, Pinus eldarica Medw (P. eldarica) nuts are used as
food. P. eldarica belongs to the botanical family pinaceae* Correspondence: Fakhrzad@tums.ac.ir
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tween Europe and Asia, and it is also spread in Iran,
Afghanistan and Pakistan [5, 6].
In Russia and the Central Asian countries the P. eldarica
needles, buds, resin and nuts have been widely used in
traditional medicine for the treatment of bronchial asthma,
and various skin diseases [7, 8]. Several components such
as β-caryophyllene, α-pinene, longifolene, α-humulene,
δ-3-carene and β-pinene with antioxidant properties have
been reported in the P. eldarica nut oil [9].
In our previous study high concentrations of total
polyphenols and fatty acids have been detected in P.
eldarica nut as indication of its antioxidant properties
[10]. Experimental studies strongly support the efficacy of
polyphenols and unsaturated fatty acids in the treatment
of chronic diseases including cardiovascular disordersccess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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possible anti-hypercholesterolemic and anti-atherosclerotic
effects of P. eldarica nut in hypercholesterolemic rabbits.
Methods
Chemicals
Methanol, phosphoric acid, chloroform, acetonitril and
sodium chloride were purchased from Merck Company
(India) nn. Ethyl acetate was purchased from Sinopharm
Chemical Reagent Company (China). Polyphenol standards:
(+) - catechin, (−) - epicatechin, Gallic acid, vanillic acid,
para coumaric acid, ferullic acid, ortho coumaric acid and
tyrosol were purchased from Sigma-Aldrich Corporation
(Germany). Cholesterol powder was purchased from Solvay
Duphar Co., Belgium.
Plant material
P. eldarica cones were collected from Chitgar Forest
Park (West of Tehran). The cones were collected be-
tween June and July of 2010. The plant was identified by
M. Ahvazi and herbarium specimen was preserved in
the herbarium of Medicinal Plants Institute (ACECR)
with Herbarium code of 689. P. eldarica cones were
dried in a dark place at room temperature. The nuts
were removed from cones and grounded to powder by
grinder.
Plant extract
The hydroalcholic extract of P. eldarica nut powder was
prepared using 70 % ethanol in water, using percolation
method at room temperature. The powdered plant material
was soaked initially in a solvent in a percolator and then
sufficient amount of the solvent was added to cover mater-
ial and kept for 24 h with occasional stirring. Then the out-
let of the percolator was opened and the liquid contained
therein was allowed to drip slowly. The procedure was re-
peated twice and the combined extractions were clarified
by filtration and concentrated to dryness on rotary evapor-
ator at a maximum of 40 °C temperature and under re-
duced pressure.
Polyphenol determination
The polyphenol content of P. eldarica nut was deter-
mined by the High-performance liquid chromatography
(HPLC) method developed by Dogan et al. [15]. In brief
a standard solution was prepared by dissolving 10 mg of
(+) catechin (sigma), epicatechin (sigma), and other
phenolic compounds in 10 ml methanol and diluting
this solution with methanol HPLC grade. The range of
concentration was between 50 and 1000 μg/ml and
standard curve was linear (R2 ≥ 0.998). Then 20 μL of
sample solution was injected to the HPLC and the chro-
matogram was recorded at 280 nm. First, 20 μl of stand-
ard solution was injected and the chromatogram wasrecorded at 280 nm. Next, we compared the area of the
peaks in standard and sample chromatograms and calcu-
lated the amount of polyphenols in P. eldarica. Total
phenol was computed from measurement of individually
detected phenols [16].
Animals and diet
Forty male 6-month-old white New Zealand rabbits
(1.8–2 kg) were purchased from Razi Research Institute,
Karaj, Iran. High cholesterol diet (HCD) was prepared
by adding of 1 g cholesterol powder and 3 g corn oil to
96 g of standard laboratory food.
General procedures
Rabbits were housed individually in cages in temperature-
controlled room (24 °C) under a 12-h light/dark cycle with
free access to food and water in the Animal Research Cen-
ter of Institute of Medicinal Plants. The experimental
protocol was approved by the Iranian Institutional Animal
Ethics Committee and was conducted according to the
Iranian Institutional Animal Care Guidelines for the use
and care of experimental animal, drug, dose, and treatment
schedule.
After a 2-week adaptation period, rabbits were ran-
domly assigned to five equal groups: control (normal)
group fed on standard a diet, HCD control group fed on
HCD (1 % cholesterol), and three groups fed on HCD
and treated with P. eldarica nut in three different doses
(50, 100 and 200 mg/kg/day). The extract in the dosages
of 50, 100, 200 mg was mixed with little amount of
rabbit pellets and fed orally one hour before feeding.
The whole experiment lasted 8 weeks. Upon termination
of the study biochemical analysis of serum lipids and
pathological evaluation of aortas were performed.
Biochemical analysis
At the end of the study, the overnight fasting blood sam-
ple was taken from marginal ear veins for lipid analysis.
Fasting blood cholesterol (Cho) LDL, HDL and triglycer-
ide (TG) levels in sera were measured using enzyme
assay kits (Pars Azmun Co., Iran).
Pathological analysis
At the end of the study, rabbits were killed by chloro-
form (overdose) and their aortas were separated up to
diaphragm. The aortas were then divided into the prox-
imal, middle, and distal segments. The aortic specimens
were dehydrated in a graded series of alcohol xylene and
embedded in paraffin for light microscopic examination.
From each paraffin block, four sections of 4 mm2 were cut
and stained with hematoxylin and eosin. All sections were
evaluated microscopically for fatty streak, foam cells,
extracellular lipid core, as atheromatous plaque elements.
The degree of vascular injury and atherosclerosis was
Table 1 Percent of polyphenols in P. eldarica nut mean ± SD
[16]
Polyphenols Percent
Catechin 10.1 ± 0.18
Epicatechin 10.3 ± 0.18
Gallic acid 1.6 ± 0.09
P. coumaric acid 1.4 ± 0.12
Ferullic acid 1.7 ± 0.21
O. coumaric acid 0.12 ± 0.02
Tyrosol 29.1 ± 0.08
Dimers of catechin and epicatechin 7.5 ± 1.06
Unknown 38.18 ± 0.28
Total phenols (ppm) 483 ± 27
Huseini et al. DARU Journal of Pharmaceutical Sciences  (2015) 23:32 Page 3 of 5quantitatively measured based on lesion area (on scale of
mm2) with use of a color image analyzer (E200; Nikon,
Tokyo, Japan) [17]. Both the surgeon and the pathologist
were blinded to the control and experiment groups.Statistical analysis
All values are expressed as means ± SE. Data were ana-
lyzed by one way ANOVA, and all differences were
inspected by Duncan’s multiple test. Differences were
considered to be significant at p < 0.05.Results
The polyphenol content of the P. eldarica nut is presented
in Table 1. Considering this method more than 8 polyphe-
nols were identified in P. eldarica nut in which catechin,
epicatechin and tyrosol were highest in concentration.Table 2 The fasting blood parameters and aortic wall area percent






Control (normal) 60.4 ± 15.8 31.4 ± 4.5 9.2 ± 4.7
Control (HCD) 91.2 ± 48.9 1545.6 ± 510.6 1060.6 ± 360.5
P = 0.218* P = 0.003* P = 0.016*
P. eldarica nut extract
50 mg/kg
93.6 ± 31.2 1253.0 ± 578.0 834.4 ± 201.2
P = 0.929** P = 0.421** P = 0.544**
P. eldarica nut extract
100 mg/kg
102.2 ± 37.7 834.4 ± 201.2 552.4 ± 158.2
P = 0.700** P = 0.020** P = 0.034**
P. eldarica nut extract
200 mg/kg
108.8 ± 28.0 710.4 ± 448.0 438.4 ± 292.2
P = 0.505** P = 0.025** P = 0.020**
P < 0.05 was considered as statistically significant
*compared with control (normal) group
**compared with control (HCD) groupResults show that feeding the rabbits for 8 weeks with
HCD leads to a significant increase in their blood serum
total cholesterol, LDL-C and to a lesser extent in TG
levels. Results indicate that serum total cholesterol and
LDL-C levels significantly decrease in the groups treated
with 200 mg/kg/day and 100 mg/kg/day of P. eldarica
compared to the control group; although it is of note
that all of the aortic samples from HCD-fed rabbits
showed some degree of atherogenesis and none of them
were normal. There were no significant changes in fast-
ing blood TG and HDL-C levels in P. eldarica treated
groups compared to control group (Table 2) (Fig. 1).
Morphological changes of the aortic wall atheroscler-
otic involvement are shown in Fig. 1. The aortic wall
area percent in groups treated with 200 mg/kg/day and
100 mg/kg/day P. eldarica nut decreased significantly
compared to the control group (Table 2).
Discussion
The results suggest that P. eldarica nut extract reduced
total cholesterol, LDL-C and extent of aortic atheroscler-
otic involvement in hypercholesterolemic rabbits. The
mechanism underlying inhibition of aortic atheroscler-
otic progression by P. eldarica nut extract may not be
solely due to its lipid lowering effect, as the levels of
serum total cholesterol and LDL-C were remarkably
higher in cholesterol-fed rabbits than in normal ones.
Other mechanisms may also play a role for such
effect. Increases in serum cholesterol and LDL-C and
consequent oxidation of LDL-C are essential steps for
development of atherosclerotic plaques [2]. In fact for-
mation of oxidatively-modified LDL-C is the first step of
atherogenesis in so-called “oxidation hypothesis” [17].(mm2) after 8 weeks of high cholesterol diet (HCD) fed rabbits
compared with high control HCD fed rabbits (mean ± SD)
HDL (mg/
dl)
Aortic wall area percent
(mm2)
Percent of aortic wall area
changes
13.2 ± 3.2 0.247 ± 0.032
113.4 ± 55.8 0.296 ± 0.049 16.55↑ Compared with control
(normal)
P = 0.003* P = 0.005*
87.6 ± 17.7 0.276 ± 0.048 6.76↓ compared with control
(HCD)
P = 0.351** P = 0.350**
90.2 ± 15.9 0.261 ± 0.038 11.83↓ compared with control
(HCD)
P = 0.410** P = 0.048**
99.4 ± 11.8 0.259 ± 0.042 12.50↓compared with control
(HCD)
P = 0.47**0 P = 0.032**
Fig. 1 Morphological changes of the aortic wall atherosclerotic involvement. a Normal rabbits fed on standard laboratory diet, b Rabbits fed on
HCD; c Rabbits fed on HCD and treated with 50 mg/kg of P. eldarica; d Rabbits fed on HCD and treated with 100 mg/kg of P. eldarica; e Rabbits
fed on HCD and treated with 200 mg/kg of P. eldarica
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C to oxidation independently correlates with the extent
of atherosclerosis [18]. It is now established that inhib-
ition of oxidative stress and lipid oxidation could have
beneficial effects on regression of atherogenesis [19].
P. eldarica nuts contain high concentrations of polyphe-
nols and flavonoids (Table 1) [10]. Several data suggested
that, flavonoids improve dyslipidemia, inhibit low-
density lipoprotein cholesterol oxidation and protect
vascular endothelium against oxidative damage [20–22].
Furthermore, catechin and epicatechin which are found
in high concentrations in P. eldarica nuts are also main
chemical constituent of other Pinus species barks such
as French matitime pine bark extract (pycnogenol) [23].
Several studies have shown the beneficial effects of pyc-
nogenol for health to be mainly due to its antioxidantproperties and consequent excellent free radical scaven-
ging function [24–26]. In addition other components
such as tyrosol with antioxidant properties which are
present in high concentrations in P. eldarica nuts may
directly or indirectly influence lipoprotein and cellular
metabolism against atherogenesis [10, 27].
On the other hand, the observed anti-atherogenic ef-
fects of P. eldarica nut in the rabbits may also be in part
due to appreciable amounts of essential oils such as α-
pinene, β-pinene and β-caryophyllene present in this nut
[9]. The antioxidant properties of α-pinene, β-pinene
and β-caryophyllene are reported in other studies [28].
Of note the limitations of this study were lack of deter-
mination of the essential oil components and antioxidant
properties of P. eldarica nut extract. To our knowledge
this is the first trial on the anti-atherosclerotic and
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cholesterolemic rabbits. In a similar study we also have
recently shown the beneficial effects of Pinus eldarica
nut extract on blood glucose and cholesterol levels in
hypercholesterolemic alloxan-induced diabetic rats [29].
As P. eldarica nuts are usually safe and used as food,
further investigation of their clinical efficacy in the treat-
ment of hypercholesterolemia is suggested.
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